According to the FDA label, semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or prior serious hypersensitivity to semaglutide
Multiple Indian companies have publicly announced approvals, partnerships, and dayone launch planssetting up a fastmoving, highstakes market with pricing pressure, device differentiation, and execution excellence as the primary determinants of success
While cost and insurance coverage remain the leading reasons why consumers have stopped taking a GLP-1 medication, that percentage is down from early April data
Progress should be assessed using a combination of body composition measurements, strength improvements, and visual changes rather than relying solely on scale weight, as this may drop more slowly if you are preserving or building muscle
A.StoffersD.et al